All Categories
 
Categories
Contributors
Tags
Cancer Research X
 
   
5 items found in 1 pages
STAMPEDE (part 3): Impact and legacy with Max Parmar and Nick James
STAMPEDE is a long-running trial in advanced prostate cancer, in which nearly 12,000 men have taken part. Thanks to its multi-arm multi-stage platform design, STAMPEDE has tested many different treatments and directly led to improvements in the standard of prostate cancer care several times. This Trial Talk podcast mini-series will explore the trial’s journey from its inception in the early 2000s to the end of patient recruitment in March 2023. In the final part, Max Parmar and Nick James look back over the trial’s impact on clinical practice and platform trial design, and look forward to STAMPEDE2 and their hopes for the future of prostate cancer research. - Further information is available on the STAMPEDE study page at www.mrcctu.ac.uk For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk For more information and to access the transcript: bit.ly/3OQWhV8 As a listener, your opinion is very valuable to us. Please help us to improve the podcast in future
6
8/23/2023
Clinical Seminar Series - John Bridgewater and Kai-Keen Shiu
Thursday 4th June 2020 In this seminar Dr John Bridgewater discusses targeted therapies for biliary tract cancer and Dr Kai-Keen Shiu explains more about immunotherapy for colorectal cancer.
73
6/18/2020
TRACERx: How whole-genome doubling helps cancer survive
Dr Nicholas McGranahan, joint lead for the TRACERx team at UCL, explains the survival advantage to cancer of doubling its genome: If one copy of the genome has a lethal mutation, the cell could continue to survive and divide, thanks to its second copy - a genetic 'spare tyre.' Read more on the CRUK blog: https://scienceblog.cancerresearchuk.org/2020/03/05/evolution-sex-and-tracerx-how-cancers-spare-tyre-helps-it-survive/ Research paper: Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution. Nature Genetics
365
5/21/2020
Director's Overview - UCL Cancer Institute
Professor Tariq Enver. Presentation 15 May 2019
53
7/9/2019
Heterocellular signalling in cancer
The Cell Communication Lab at UCL Cancer Institute, led by Dr Chris Tape, studies how cancer-causing mutations communicate with non-cancerous cells to drive colorectal cancer (CRC).
7926
7/26/2017